PMC3581357_01
Tumor marker (CA19.9) evolution during therapy.. Abbreviations: IGFR1, insulin-like growth factor 1; mTOR, mammalian target of rapamycin; IV, intravenous; PO, per os; qd, once a day.
ott-6-095Fig1.jpg
PMC3581357_01_ott-6-095Fig1.jpg
f1-ott-6-095
After two weeks, while the patient had a rapid decrease of the CA19.9 level (Figure 1), the combined therapy was associated with a significant digestive and urinary radiation recall syndrome.